{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:07:06Z","timestamp":1784966826969,"version":"3.55.0"},"reference-count":32,"publisher":"Society of Nuclear Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.2967\/jnumed.122.265159","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T21:25:45Z","timestamp":1675373145000},"page":"918-923","source":"Crossref","is-referenced-by-count":3,"title":["An Analysis of the Distribution of PSMA PET\/CT\u2013Positive Lymph Nodes and Their Coverage by Different Elective Nodal Radiation Volumes in Postoperative Prostate Cancer Patients"],"prefix":"10.2967","volume":"64","author":[{"given":"Christian","family":"Trapp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmytro","family":"Oliinyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rogowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieke","family":"von Bestenbostel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Ganswindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwuka","family":"Eze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bartenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harun","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Unterrainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Westhofen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang G.","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Unterrainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Belka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina-Sophie","family":"Schmidt-Hegemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"2023060112150680000_64.6.918.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.7893"},{"key":"2023060112150680000_64.6.918.2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/bju.14241","article-title":"Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit","volume":"123","author":"Gupta","year":"2019","journal-title":"BJU Int."},{"key":"2023060112150680000_64.6.918.3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/cncr.30373","article-title":"The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer","volume":"123","author":"Jegadeesh","year":"2017","journal-title":"Cancer."},{"key":"2023060112150680000_64.6.918.4","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(21)01790-6","article-title":"The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology\/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial","volume":"399","author":"Pollack","year":"2022","journal-title":"Lancet."},{"key":"2023060112150680000_64.6.918.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.08.002"},{"key":"2023060112150680000_64.6.918.6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ijrobp.2015.03.021","article-title":"Consensus guidelines and contouring atlas for pelvic node delineation in prostate and pelvic node intensity modulated radiation therapy","volume":"92","author":"Harris","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2023060112150680000_64.6.918.7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.eururo.2016.07.043","article-title":"Patterns of lymph node failure after dose-escalated radiotherapy: implications for extended pelvic lymph node coverage","volume":"71","author":"Spratt","year":"2017","journal-title":"Eur Urol."},{"key":"2023060112150680000_64.6.918.8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.prro.2017.03.002","article-title":"Patterns of lymph node positivity on 11C-acetate PET imaging in correlation to the RTOG pelvic radiation field for prostate cancer","volume":"7","author":"McClinton","year":"2017","journal-title":"Pract Radiat Oncol."},{"key":"2023060112150680000_64.6.918.9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.urology.2018.12.055","article-title":"Location of recurrence by gallium-68 PSMA-11 PET scan in prostate cancer patients eligible for salvage radiotherapy","volume":"129","author":"Boreta","year":"2019","journal-title":"Urology."},{"key":"2023060112150680000_64.6.918.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.201749"},{"key":"2023060112150680000_64.6.918.11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.euo.2020.04.004","article-title":"PSMA-PET\/CT-based lymph node atlas for prostate cancer patients recurring after primary treatment: clinical implications for salvage radiation therapy","volume":"4","author":"Schiller","year":"2021","journal-title":"Eur Urol Oncol."},{"key":"2023060112150680000_64.6.918.12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12885-020-06911-4","article-title":"PEACE V: salvage treatment of oligorecurrent nodal prostate cancer metastases (STORM)\u2014a study protocol for a randomized controlled phase II trial","volume":"20","author":"De Bruycker","year":"2020","journal-title":"BMC Cancer."},{"key":"2023060112150680000_64.6.918.13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijrobp.2020.08.034","article-title":"NRG Oncology updated international consensus atlas on pelvic lymph node volumes for intact and postoperative prostate cancer","volume":"109","author":"Hall","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2023060112150680000_64.6.918.14","doi-asserted-by":"crossref","first-page":"590722","DOI":"10.3389\/fonc.2020.590722","article-title":"The distribution of pelvic nodal metastases in prostate cancer reveals potential to advance and personalize pelvic radiotherapy","volume":"10","author":"Filimonova","year":"2021","journal-title":"Front Oncol."},{"key":"2023060112150680000_64.6.918.15","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.eururo.2018.10.044","article-title":"Nodal oligorecurrent prostate cancer: anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates","volume":"75","author":"De Bruycker","year":"2019","journal-title":"Eur Urol."},{"key":"2023060112150680000_64.6.918.16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","article-title":"Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial","volume":"5","author":"Fendler","year":"2019","journal-title":"JAMA Oncol."},{"key":"2023060112150680000_64.6.918.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.219501"},{"key":"2023060112150680000_64.6.918.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3078-6"},{"key":"2023060112150680000_64.6.918.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.160382"},{"key":"2023060112150680000_64.6.918.20","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13397"},{"key":"2023060112150680000_64.6.918.21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"2023060112150680000_64.6.918.22","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-014-0063-1"},{"key":"2023060112150680000_64.6.918.23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13014-018-0983-4","article-title":"Outcome after PSMA PET\/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy","volume":"13","author":"Schmidt-Hegemann","year":"2018","journal-title":"Radiat Oncol."},{"key":"2023060112150680000_64.6.918.24","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","article-title":"68Ga-PSMA PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging\u2014version 1.0","volume":"44","author":"Fendler","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023060112150680000_64.6.918.25","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.211.3.r99jn40815"},{"key":"2023060112150680000_64.6.918.26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13014-016-0615-9","article-title":"Distribution of prostate nodes: a PET\/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment","volume":"11","author":"Hegemann","year":"2016","journal-title":"Radiat Oncol."},{"key":"2023060112150680000_64.6.918.27","first-page":"127","article-title":"Radiolabelled choline versus PSMA PET\/CT in prostate cancer restaging: a meta-analysis","volume":"9","author":"Treglia","year":"2019","journal-title":"Am J Nucl Med Mol Imaging."},{"key":"2023060112150680000_64.6.918.28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2021.06.010","article-title":"OLIGOPELVIS GETUG P07, a multicenter phase II trial of combined high-dose salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses in prostate cancer","volume":"80","author":"Supiot","year":"2021","journal-title":"Eur Urol."},{"key":"2023060112150680000_64.6.918.29","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.20.03282","article-title":"Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase III randomized controlled trial","volume":"39","author":"Murthy","year":"2021","journal-title":"J Clin Oncol."},{"key":"2023060112150680000_64.6.918.30","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.eururo.2019.07.009","article-title":"Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer: a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy","volume":"76","author":"De Bleser","year":"2019","journal-title":"Eur Urol."},{"key":"2023060112150680000_64.6.918.31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.euo.2022.03.004","article-title":"68Ga-PSMA versus 18F-PSMA positron emission tomography\/computed tomography in the staging of primary and recurrent prostate cancer. A systematic review of the literature","volume":"5","author":"Evangelista","year":"2022","journal-title":"Eur Urol Oncol."},{"key":"2023060112150680000_64.6.918.32","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","article-title":"Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 imaging trial","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA Oncol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.122.265159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T19:16:11Z","timestamp":1685646971000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.122.265159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,1]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.2967\/jnumed.122.265159"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.122.265159","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]}}}